Arkolith/Insider Trading/ACST/Form 4

Olds Donald

DirectorAcasti Pharma Inc. (ACST) · full profile →Form 4 · filed Sep 5, 2023
Net Buying
Open-Market Buys
$781
Open-Market Sells
$0
Net Open-Market Flow
$781
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2023Buy(P)381$2.05$781381

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-23-017516) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML